Your urologist will use several tests to determine how severe your BPH is and whether it affects your bladder health. They may recommend watchful waiting if your BPH is mild. Watchful waiting means ...
A regulatory decision is expected in the third quarter of 2024. The Food and Drug Administration (FDA) has accepted the supplemental New Drug Application (sNDA) for vibegron for the treatment of men ...
WAYNE, Pa., July 14, 2020 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) today announced results of a new survey showing that the majority of American men over age 40 are prescribed multiple ...
TORONTO, June 10, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable ...
Medical Device Network on MSN
FDA clears Francis Medical’s water vapour ablation treatment for prostate cancer
Francis Medical’s Vanquish device for treating intermediate-risk prostate cancer has been cleared by the US Food and Drug ...
Investor's Business Daily on MSN
Janux Therapeutics Craters 53% On Prostate Cancer Update; Is It An 'Overreaction'?
Janux Therapeutics stock crashed Tuesday on what one analyst called an "overreaction" to the company's prostate cancer ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback